Tuttle Capital Management, LLC Pfizer Inc Transaction History

Tuttle Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $901,053 - $1.02 Million	25,092 New	25,092 $983,000
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $906,641 - $1.02 Million	-27,072 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $623,646 - $793,020	18,633 Added 220.8%	27,072 $997,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $267,938 - $314,352	8,439 New	8,439 $310,000
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $1.24 Million - $1.36 Million	-33,030 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$38.47 - $43.86 $1.27 Million - $1.45 Million	33,030 New	33,030 $1.44 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.